Conjunctivitis in atopic dermatitis patients treated with dupilumab-Worsening of pre-existing disease or de novo development?

C M Olesen; A S Halling

doi:10.1111/jdv.19126

Conjunctivitis in atopic dermatitis patients treated with dupilumab-Worsening of pre-existing disease or de novo development?

Dermatology, Department of

Original language	English
Journal	Journal of the European Academy of Dermatology and Venereology : JEADV
Volume	37
Issue number	7
Pages (from-to)	1258-1259
Number of pages	2
ISSN	0926-9959
DOIs	https://doi.org/10.1111/jdv.19126
Publication status	Published - Jul 2023

Keywords

Humans
Preexisting Condition Coverage
Dermatitis, Atopic
Antibodies, Monoclonal, Humanized
Conjunctivitis

Access to Document

10.1111/jdv.19126

Cite this

@article{6e37b51785b043a1aebd9e9e3fca519f,

title = "Conjunctivitis in atopic dermatitis patients treated with dupilumab-Worsening of pre-existing disease or de novo development?",

keywords = "Humans, Preexisting Condition Coverage, Dermatitis, Atopic, Antibodies, Monoclonal, Humanized, Conjunctivitis",

author = "Olesen, {C M} and Halling, {A S}",

year = "2023",

month = jul,

doi = "10.1111/jdv.19126",

language = "English",

volume = "37",

pages = "1258--1259",

journal = "Journal of the European Academy of Dermatology and Venereology : JEADV",

issn = "0926-9959",